Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s share price fell 29.3% during mid-day trading on Tuesday . The company traded as low as GBX 14 ($0.18) and last traded at GBX 19.80 ($0.25). 368,578 shares changed hands during mid-day trading, an increase of 370% from the average session volume of 78,498 shares. The stock had previously closed at GBX 28 ($0.35).
Celadon Pharmaceuticals Price Performance
The company has a current ratio of 1.92, a quick ratio of 6.97 and a debt-to-equity ratio of 194.82. The company has a 50 day simple moving average of GBX 29.71 and a 200 day simple moving average of GBX 54.25. The stock has a market cap of £10.47 million, a P/E ratio of -193.75 and a beta of -0.26.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than Celadon Pharmaceuticals
- Trading Stocks: RSI and Why it’s Useful
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Buy P&G Now, Before It Sets A New All-Time High
- Williams-Sonoma Stock: Buy It and Never Let It Go
- Quiet Period Expirations Explained
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
